Operating profit before deduction of amortization: Precigen (PGEN)
Precigen, Inc. (PGEN) focuses on breakthrough immuno-oncology methods and HPV treatments. This line chart of current EBITDA on GURU.Markets reflects a trend where 38.27 becomes the new value for the metric. Precigen, Inc. (PGEN) is implementing UltraCAR-T technology for rapid cell production within clinics, reducing expenditures on manufacturing plants. Simultaneously, the developer is mitigating risks by allocating resources across various gene projects.
Precigen (PGEN) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
PGEN - Net Profit|Future Profit Precigen, Inc.|PGEN - P/E Multiple|Market Cap to Projected Earnings precigen.com|PGEN - PEG Multiple|Enterprise Value to EBITDA Multiple Precigen|PGEN - Operating profit EBITDA|Net earnings per one share for the last twelve months Precigen|PGEN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months precigen.com|PGEN - Net earnings per share growth this year|Expected earnings per share trend next year Precigen, Inc.
Analysis of all company metrics:Precigen Corp, PGEN
For the biotech sector, Precigen, Inc. (PGEN) finds that the fundamental significance of operating cash flow determines the viability of clinical developments. By analyzing the absolute cash result of operations, an investor sees earnings before interest, taxes, depreciation, and amortization. This metric strips the business of its debt load, demonstrating the real ability to generate cash. In the absence of seasonality, this chart reflects the efficiency of capital management. Stable growth of this indicator minimizes the risks of dependence on external financing prior to product commercialization.
Competitors of Precigen, Inc. (PGEN)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VERA|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|pharvaris.com - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Operating profit EBITDA PHAR|Operating profit before deduction of amortization Nektar Corp NKTR|Operating profit EBITDA UPB (Upstream Bio Inc)|Operating income before deduction of amortization zenasbio.com (ZBIO)|Immunome - Operating profit EBITDA|Operating profit before depreciation charges Gossamer Bio Inc (GOSS)|KALV: Operating profit EBITDA|Profit before interest, taxes and amortization Septerna Pharma (SEPN)|Profit before payment of interest, taxes and amortization Pieris Pharmaceuticals|Operating profit before amortization SVRA (savarapharma.com)|Operating profit before deduction of amortization RIGL (Rigel Pharmaceuticals, Inc.)|ANAB (AnaptysBio Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATXS (Astria Pharma)|Operating income before deduction of amortization enGene Corp (ENGN)|RAPT - Profit before payment of interest, taxes and amortization|JBIO (Aerovate Therapeutics Inc) - Operating profit before amortization|ACRS: Operating profit EBITDA|Operating profit before deduction of amortization Kyverna Therapeutics Inc.|Operating profit before deduction of amortization TLSA|Cabaletta Bio Inc (CABA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Ventyx Biosciences (VTYX)|THTX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA AVTX (Avalo Therapeutics)|Operating profit before depreciation charges Eledon Pharmaceuticals Inc.|Agenus Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Climb Bio, Inc|Zura Bio (ZURA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ATYR|Profit before payment of interest, taxes and amortization Adagene Inc|Ikena Oncology, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA STTK|EQ (equilliumbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Operating profit EBITDA Immunic Therapeutics IMUX|ATRA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization IFRX (InflaRx N.V.)|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Adicet Bio, Inc.|CELU (Celularity Inc) - Operating profit EBITDA|Operating profit EBITDA inmunebio.com|Operating profit before deduction of amortization BRNS (Barinthus Biotherapeutics plc)|KZR (Kezar Life Sciences Inc.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Operating income before deduction of amortization Akari Therapeutics, Plc (AKTX)|ENLV - Profit before payment of interest, taxes and amortization|Q32 Bio Inc. (QTTB) - Operating profit before deduction of amortization|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Edesa Biotech Inc|Operating profit before deduction of amortization IBIO|Operating profit EBITDA Carisma Tx|Profit before payment of interest, taxes and amortization XTL Biopharmaceuticals (XTLB)|boltbio.com - Operating profit before amortization|Operating profit EBITDA HCWB (HCW Biologics)|Aptevo Therapeutics, Inc. (APVO) - Profit before interest, taxes and amortization|AIM - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ADTX|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|xortx.com - Income before deduction of interest, taxes and amortization|HIND (Vyome Holdings) - Operating profit EBITDA|Profit before interest, taxes and amortization Revelation Biosciences Inc REVB|Operating profit EBITDA INDP|Operating profit before deduction of amortization BiondVax Pharmaceuticals SCNI|Operating profit EBITDA CALI (CalciMedica)|Operating income before deduction of amortization Affimed NV (AFMD)|Allakos Therapeutics - Operating profit EBITDA|Operating profit before depreciation charges HOOKIPA Pharma Inc. (HOOK)|IGMS: Operating profit EBITDA|Profit before interest, taxes and amortization iTeos Pharma (ITOS)|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
